High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
The average brokerage recommendation (ABR) for CrowdStrike (CRWD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Based on the average brokerage recommendation (ABR), Nutanix (NTNX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
The average brokerage recommendation (ABR) for Lowe's (LOW) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Interactive Brokers' 8.6% monthly slide may offer a buying opportunity as product expansion and growth forecasts support its outlook. Let's find out.
PUMP pairs strong cash flow from Permian completions with PROPWR growth, but rich valuation, higher spending and execution demands raise the bar for future gains.
Shares of electronics retailer Best Buy (NYSE:BBY) fell 2.8% in the afternoon session after BofA Securities resumed coverage on the stock with an underperform rating. The bank set a price target of $80, below the stock's recent trading price. An "underperform" rating suggests an analyst believes the stock is likely to do slightly worse than the overall market. The negative sentiment was compounded by leadership uncertainty, as the company is searching for a new Chief Financial Officer (CFO) foll
Senate to try to fit in an initial vote on the Clarity Act, Majority Leader Thune said. Cathie Wood buys nearly $10 mil in Coinbase, Circle.
These stocks could all make big moves as they report earnings.
Higher crack spreads driven by Strait of Hormuz supply disruptions pushed the refiner's quarterly net income to $5.1 billion
Palantir‘s (NASDAQ:PLTR) stock is ripping higher early Tuesday, with Palantir shares up 16% to $145.50 after the company posted a blowout Q2 2026 and raised its full-year outlook. The rally follows Monday’s after-close earnings release, and it hasn’t spread to peer agentic-AI names. The bounce comes off a rough stretch. Palantir stock was down 29% ... Palantir Rockets 16% After Q2 Blowout; C3.ai, UiPath Sit Out the Rally
Stock Market Today: The Dow Jones index rallies Tuesday as Caterpillar and Palantir surge on earnings. SpaceX earnings are due late.
Snap stock soared on Tuesday after a blowout quarter for the social media company, buoyed by the World Cup.
Snap stock soared on Tuesday after a blowout quarter for the social media company, buoyed by the World Cup.
ZS' record-large deal activity is fueled by Zero Trust adoption, AI protection, platform consolidation and surging Z-Flex contract value.
Website building platform Wix (NASDAQ:WIX) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 14.9% year on year to $563.1 million. Its non-GAAP profit of $1.39 per share was 15.3% above analysts’ consensus estimates.
PSEG (PEG) delivered earnings and revenue surprises of +7.50% and -5.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
TransDigm (TDG) delivered earnings and revenue surprises of +5.64% and +2.56%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
ImmunityBio (IBRX) delivered earnings and revenue surprises of +11.11% and +5.76%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Fidelity National (FIS) delivered earnings and revenue surprises of +0.68% and -0.23%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Arvinas (ARVN) delivered earnings and revenue surprises of +1,175.00% and +562.56%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
These companies have some exciting growth opportunities, but their shares are down more than 35% this year.
Global pharmaceutical company Pfizer (NYSE:PFE) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 2.6% year on year to $15.03 billion. The company expects the full year’s revenue to be around $61.5 billion, close to analysts’ estimates. Its non-GAAP profit of $0.77 per share was 12.9% above analysts’ consensus estimates.
Viper's Q2 earnings surpass estimates as higher production and realized oil prices drive strong growth and lift its 2026 outlook.
Palantir's AI Growth Is Accelerating. Wall Street Just Raised Its Price Target
Snap (NYSE:SNAP) shares surged more than 8% in U. S.
Qnity Electronics, Inc. (NYSE:Q) reported second-quarter 2026 results that comfortably surpassed Wall Street expectations and raised its financial guidance for the full year, sending the company’s shares 10.
Qnity Electronics beat Wall Street's targets for the second quarter and raised its guidance for the full year. Qnity stock rose.
F's Q2 earnings beat, raised 2026 guidance, improving product mix and narrowing EV losses strengthen its investment case.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
